These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7070978)

  • 1. [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)].
    Wolf LM; Houdent C; Laudat MH; Brasseur G; Balacheff O; Uzac L
    Nouv Presse Med; 1982 Mar; 11(11):855-7. PubMed ID: 7070978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
    N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM; Salen G; Shefer S
    N Engl J Med; 1984 Dec; 311(26):1649-52. PubMed ID: 6504105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebrotendinous xanthomatosis. 2 cases with magnetic resonance imaging].
    Rogelet P; Gérard JM; Michotte A; Masingue M; Destée A
    Rev Neurol (Paris); 1992; 148(8-9):541-5. PubMed ID: 1494725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebrotendinous xanthomatosis].
    Berginer VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):13-22. PubMed ID: 1333699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Van Bogaert's cerebrotendinous xanthomatosis. A study of 3 cases].
    Laurent A; Dairou F; Luc G; Truffert J; Lapresle J; de Gennes JL
    Ann Med Interne (Paris); 1988; 139(6):395-402. PubMed ID: 3066249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
    Kondo R; Wakamatsu N; Ishikawa A; Yuasa T; Miyatake T
    Rinsho Shinkeigaku; 1991 Jun; 31(6):677-9. PubMed ID: 1934787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebrotendinous xanthomatosis].
    Burghaus L; Liu W; Haupt WF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Berginer V
    Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Timely treatment of cerebrotendinous xanthomatosis, a hereditary disorder of cholesterol metabolism].
    Waterreus RJ; de Jager AE; Koopman BJ; Wolthers BG; Suurmeyer AJ
    Ned Tijdschr Geneeskd; 1984 Aug; 128(34):1604-7. PubMed ID: 6483031
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebrotendinous xanthomatosis is treatable.
    White SW
    Pediatr Dermatol; 1985 Jul; 2(4):294-6. PubMed ID: 3925446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
    Chang WN; Kuriyama M; Chee EC
    J Formos Med Assoc; 1994 Mar; 93(3):256-9. PubMed ID: 7920069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
    Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
    Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
    Kimura S; Beppu T; Kugai N; Koide Y; Fujita T; Iida K; Yamashita N; Yamashita K; Seyama Y
    Jpn J Med; 1982 Jul; 21(3):210-5. PubMed ID: 7143816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
    Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of LDL-apheresis on a case of Cerebrotendinous Xanthomatosis].
    Fukuo Y; Hayama N; Hara K; Terashi A; Seta K
    Rinsho Shinkeigaku; 1989 Feb; 29(2):196-201. PubMed ID: 2752648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrotendinous xanthomatosis.
    Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
    J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.